HomeCompareSSPX vs JNJ

SSPX vs JNJ: Dividend Comparison 2026

SSPX yields 0.20% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $79.00 in total portfolio value· pulled ahead in Year 10
10 years
SSPX
SSPX
● Live price
0.20%
Share price
$31.50
Annual div
$0.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$19.81
Full SSPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SSPX vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSSPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SSPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SSPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SSPX
Annual income on $10K today (after 15% tax)
$16.62/yr
After 10yr DRIP, annual income (after tax)
$16.84/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $686.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SSPX + JNJ for your $10,000?

SSPX: 50%JNJ: 50%
100% JNJ50/50100% SSPX
Portfolio after 10yr
$20.0K
Annual income
$423.79/yr
Blended yield
2.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SSPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SSPX buys
0
JNJ buys
0
No recent congressional trades found for SSPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSSPXJNJ
Forward yield0.20%3.36%
Annual dividend / share$0.06$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$19.9K$20.0K
Annual income after 10y$19.81$827.78
Total dividends collected$197.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SSPX vs JNJ ($10,000, DRIP)

YearSSPX PortfolioSSPX Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,720$19.56$10,676$355.77+$44.00SSPX
2$11,490$19.59$11,407$389.39+$83.00SSPX
3$12,313$19.63$12,198$426.53+$115.00SSPX
4$13,195$19.66$13,056$467.62+$139.00SSPX
5$14,138$19.69$13,987$513.12+$151.00SSPX
6$15,148$19.72$14,998$563.56+$150.00SSPX
7$16,228$19.74$16,098$619.52+$130.00SSPX
8$17,384$19.76$17,295$681.69+$89.00SSPX
9$18,620$19.79$18,599$750.82+$21.00SSPX
10← crossover$19,943$19.81$20,022$827.78$79.00JNJ

SSPX vs JNJ: Complete Analysis 2026

SSPXStock

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities that are economically tied to the U.S. The fund generally invests in a core group of 30-50 equity securities, which consist primarily of common stocks, but may also include other types of instruments, such as depository receipts and warrants. The fund will invest primarily in larger, well-established companies but may also invest in mid- and small-sized companies.

Full SSPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SSPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SSPX vs SCHDSSPX vs JEPISSPX vs OSSPX vs KOSSPX vs MAINSSPX vs ABBVSSPX vs MRKSSPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.